Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 59 citing articles:

Targeting gut microbiota and metabolism as the major probiotic mechanism - An evidence-based review
Teng Ma, Xin Shen, Xuan Shi, et al.
Trends in Food Science & Technology (2023) Vol. 138, pp. 178-198
Open Access | Times Cited: 146
Stronger gut microbiome modulatory effects by postbiotics than probiotics in a mouse colitis model
Tao Zhang, Weiqin Zhang, Cuijiao Feng, et al.
npj Science of Food (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 58
Bifidobacterium lactis Probio-M8 improves bone metabolism in patients with postmenopausal osteoporosis, possibly by modulating the gut microbiota
Feiyan Zhao, Zhen-Guo GUO, Lai‐Yu Kwok, et al.
European Journal of Nutrition (2022)
Closed Access | Times Cited: 42
Effect of the probiotic strain, Lactiplantibacillus plantarum P9, on chronic constipation: A randomized, double-blind, placebo-controlled study
Teng Ma, Ni Yang, Yong Xie, et al.
Pharmacological Research (2023) Vol. 191, pp. 106755-106755
Open Access | Times Cited: 27
Probiotics Mediate Intestinal Microbiome and Microbiota-Derived Metabolites Regulating the Growth and Immunity of Rainbow Trout (Oncorhynchus mykiss)
Chunyan Zhao, Xianhui Men, Yongji Dang, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 25
Adjunctive Probio-X Treatment Enhances the Therapeutic Effect of a Conventional Drug in Managing Type 2 Diabetes Mellitus by Promoting Short-Chain Fatty Acid-Producing Bacteria and Bile Acid Pathways
Ye Chen, Xin Shen, Teng Ma, et al.
mSystems (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 23
Targeting the Gut Microbiome to Treat Cardiometabolic Disease
Panagiotis Theofilis, Panayotis K. Vlachakis, Evangelos Oikonomou, et al.
Current Atherosclerosis Reports (2024) Vol. 26, Iss. 2, pp. 25-34
Closed Access | Times Cited: 10
Advancing lifelong precision medicine for cardiovascular diseases through gut microbiota modulation
Bozhong Shi, Haoyu Li, Xiaomin He
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 10
An orally administered bacterial membrane protein nanodrug ameliorates doxorubicin cardiotoxicity through alleviating impaired intestinal barrier
Zhen Li, Junyue Xing, Xiaohan Ma, et al.
Bioactive Materials (2024) Vol. 37, pp. 517-532
Open Access | Times Cited: 9
Lactiplantibacillus plantarum strains KABP011, KABP012, and KABP013 modulate bile acids and cholesterol metabolism in humans
Teresa Padró, Victoria de Santisteban Villaplana, Pol Huedo, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 7, pp. 708-722
Open Access | Times Cited: 6
Impact of the gut microbiome on atherosclerosis
Y. Mao, Chao Kong, Tongtong Zang, et al.
mLife (2024) Vol. 3, Iss. 2, pp. 167-175
Open Access | Times Cited: 6
The potential preventive effect of probiotics, prebiotics, and synbiotics on cardiovascular risk factors through modulation of gut microbiota: A review
Fahimeh Ghanbari, Samira Hasani, Zahra Aghili, et al.
Food Science & Nutrition (2024) Vol. 12, Iss. 7, pp. 4569-4580
Open Access | Times Cited: 6
Gut Microbiota and Coronary Artery Disease: Current Therapeutic Perspectives
Themistoklis Katsimichas, Panagiotis Theofilis, Konstantinos Tsioufis, et al.
Metabolites (2023) Vol. 13, Iss. 2, pp. 256-256
Open Access | Times Cited: 15
Comorbidity of Anxiety and Hypertension: Common Risk Factors and Potential Mechanisms
Tingting Qiu, Zhiming Jiang, Xuancai Chen, et al.
International Journal of Hypertension (2023) Vol. 2023, pp. 1-14
Open Access | Times Cited: 15
Metabolite acetyl- L-carnitine participates in Bifidobacterium animalis F1-7 to ameliorate atherosclerotic inflammation by downregulating theTLR4/NF-κB pathway
Xi Liang, Zhe Zhang, Xiaoying Tian, et al.
Deleted Journal (2023) Vol. 13, Iss. 2, pp. 813-822
Open Access | Times Cited: 13
Probiotics alleviate constipation and inflammation in late gestating and lactating sows
Teng Ma, Weiqiang Huang, Yalin Li, et al.
npj Biofilms and Microbiomes (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 13
Oral administration of pasteurized probiotic fermented milk alleviates dextran sulfate sodium-induced inflammatory bowel disease in rats
Cuijiao Feng, Weiqin Zhang, Tao Zhang, et al.
Journal of Functional Foods (2022) Vol. 94, pp. 105140-105140
Open Access | Times Cited: 22
Probiotic Bifidobacterium animalis ssp. lactis Probio-M8 improves the properties and organic acid metabolism of fermented goat milk
Shuai Guo, Meixuan Chen, Ting Wu, et al.
Journal of Dairy Science (2022) Vol. 105, Iss. 12, pp. 9426-9438
Open Access | Times Cited: 20
Lactiplantibacillus plantarum P9 for chronic diarrhea in young adults: a large double-blind, randomized, placebo-controlled trial
Ni Yang, Teng Ma, Yong Xie, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Targeting Gut Microbiota with Probiotics and Phenolic Compounds in the Treatment of Atherosclerosis: A Comprehensive Review
José Patrocínio Ribeiro Cruz Neto, Micaelle Oliveira de Luna Freire, Deborah Emanuelle de Albuquerque Lemos, et al.
Foods (2024) Vol. 13, Iss. 18, pp. 2886-2886
Open Access | Times Cited: 4
Antiatherosclerotic effects of postbiotics
A. Vijayaganapathi, Anju K.A., G.R. Shree Kumari, et al.
Elsevier eBooks (2025), pp. 513-528
Closed Access
Mitochondrial DNA in atherosclerosis: Mechanisms, biomarker potential, and therapeutic perspectives
Ruifeng Zhang, Yifang Jiang, Guangming Zhang, et al.
International Immunopharmacology (2025) Vol. 152, pp. 114449-114449
Closed Access
Antibiotic-induced gut dysbiosis: unraveling the gut-heart axis and its impact on cardiovascular health
Navpreet Kaur, Pankaj Kumar, Mahadev Dhami, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Blood metabolites mediate causal inference studies on the effect of gut microbiota on the risk of vascular calcification
Aoran Huang, Jianshuai Ma, Huijin Zhu, et al.
Journal of Advanced Research (2025)
Open Access
Research progress of regulating intestinal flora by traditional Chinese medicine in treating coronary heart disease
Qiwen Lu, Sang Luo, Chengyan Guan, et al.
Chinese Herbal Medicines (2025)
Open Access
Page 1 - Next Page

Scroll to top